Autor: |
Shmool TA; Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom., Batens M; Drug Delivery and Disposition, KU Leuven, Leuven, Belgium., Massant J; Biological Formulation Development, UCB Pharma, Braine l'Alleud, Belgium., Van den Mooter G; Drug Delivery and Disposition, KU Leuven, Leuven, Belgium., Zeitler JA; Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom. Electronic address: jaz22@cam.ac.uk. |